Adherence to practice guidelines is associated with reduced referral times for patients with ovarian cancer

被引:5
作者
Boac, Bernadette M. [1 ]
Xiong, Yin [1 ]
Apte, Sachin M. [1 ]
Wenham, Robert M. [1 ]
Shahzad, Mian M. [1 ]
Munroe, Donald G. [3 ,4 ]
Lancaster, Johnathan M. [2 ,5 ]
Chon, Hye Sook [1 ]
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Gynecol Oncol, Tampa, FL 33612 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[3] Vermillion Inc, Austin, TX USA
[4] Ventana Med Syst Inc, Tucson, AZ USA
[5] Myriad Genet Inc, Salt Lake City, UT USA
关键词
clinical decision making; diagnostic techniques and procedures; ovarian cancer; referral and consultation; DIAGNOSIS; SURVIVAL; CARE; SYMPTOMS; MANAGEMENT; CARCINOMA; SPECIALTY; PATTERNS; IMPACT;
D O I
10.1016/j.ajog.2018.01.015
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: Patients with ovarian cancer tend to receive the highest quality of care at high-volume cancer centers with gynecological oncologists. However, the care that they receive prior to gynecological oncology consult has not been examined. We investigated the quantity and quality of care given to patients with ovarian cancer before being seen by a gynecological oncologist. OBJECTIVE: We evaluated the variability, quantity, and quality of diagnostic testing and physician-referral patterns prior to consultation with a gynecological oncologist, in women with suspicious pelvic masses seen on imaging. STUDY DESIGN: A chart review was performed on patients treated for ovarian cancer at a single institution from 2001 to 2014. We evaluated their workup in 4 categories, drawn from National Comprehensive Care Network guidelines: provider visits, abdominal/pelvic imaging, chest imaging, and tumor markers. Workup was classified as guideline adherent or guideline nonadherent. RESULTS: We identified 335 cases that met our criteria. In the provider visit category, 83.9% of patients received guideline-adherent workup: 77% in the abdominal/pelvic imaging, 98.2% in the chest imaging, and 95.2% in the tumor marker categories. Each patient's workup was assessed as a compilation of the 4 categories, yielding 65.7% patients as having received an adherent workup and 34.3% of workup as nonadherent to guidelines. The timeframe to see a gynecological oncologist for patients with guideline-adherent workup was significantly shorter than for those whose workup was nonadherant (20 vs 86 days, P<.001). A suspicious pelvic mass was identified by obstetrics-gynecology in only 23.9% of patients; 42.7% of patients did not have tumor marker testing before a gynecological oncologist consult. When an obstetrics-gynecology specialist discovered the suspicious pelvic mass, the remaining workup was more likely to be guideline adherent prior to gynecological oncologist referral than when initial imaging was not ordered by an obstetrics-ynecology specialist (P=.18) Survival was not significantly different (P=.103). CONCLUSION: With a guideline-adherent workup, including tumor marker testing, gynecological oncologist referral times can be shortened, minimizing cost inefficiencies and delays that can compromise the effectiveness of downstream care for patients with ovarian cancer. Guidelines should be disseminated beyond the obstetrics-gynecology field.
引用
收藏
页码:436.e1 / 436.e7
页数:7
相关论文
共 27 条
  • [1] American College of Obstetricians and Gynecologists, 2007, Obstet Gynecol, V110, P201
  • [2] [Anonymous], 2011, OBSTET GYNECOL
  • [3] [Anonymous], 2015, NCCN clinical practice guidelines in oncology: Prostate cancer
  • [4] Identifying symptoms of ovarian cancer: a qualitative and quantitative study
    Bankhead, C. R.
    Collins, C.
    Stokes-Lampard, H.
    Rose, P.
    Wilson, S.
    Clements, A.
    Mant, D.
    Kehoe, S. T.
    Austoker, J.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2008, 115 (08) : 1008 - 1014
  • [5] Ovarian cancer: Changes in patterns at diagnosis and relative survival over the last three decades
    Barnholtz-Sloan, JS
    Schwartz, AG
    Qureshi, F
    Jacques, S
    Malone, J
    Munkarah, AR
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 189 (04) : 1120 - 1127
  • [6] Impact of National Cancer Institute Comprehensive Cancer Centers on Ovarian Cancer Treatment and Survival
    Bristow, Robert E.
    Chang, Jenny
    Ziogas, Argyrios
    Campos, Belinda
    Chavez, Leo R.
    Anton-Culver, Hoda
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2015, 220 (05) : 940 - 950
  • [7] Adherence to Treatment Guidelines for Ovarian Cancer as a Measure of Quality Care
    Bristow, Robert E.
    Chang, Jenny
    Ziogas, Argyrios
    Anton-Culver, Hoda
    [J]. OBSTETRICS AND GYNECOLOGY, 2013, 121 (06) : 1226 - 1234
  • [8] Influence of the gynecologic oncologist on the survival of ovarian cancer patients
    Chan, John K.
    Kapp, Daniel S.
    Shin, Jacob Y.
    Husain, Amreen
    Teng, Nelson N.
    Berek, Jonathan S.
    Osann, Kathryn
    Leiserowitz, Gary S.
    Cress, Rosemary D.
    O'Malley, Cynthia
    [J]. OBSTETRICS AND GYNECOLOGY, 2007, 109 (06) : 1342 - 1350
  • [9] Ovarian cancer in the United States: Contemporary patterns of care associated with improved survival
    Cliby, William A.
    Powell, Matthew A.
    Al-Hammadi, Noor
    Chen, Ling
    Miller, J. Philip
    Roland, Phillip Y.
    Mutch, David G.
    Bristow, Robert E.
    [J]. GYNECOLOGIC ONCOLOGY, 2015, 136 (01) : 11 - 17
  • [10] Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients
    Earle, CC
    Schrag, D
    Neville, BA
    Yabroff, KR
    Topor, M
    Fahey, A
    Trimble, EL
    Bodurka, DC
    Bristow, RE
    Carney, M
    Warren, JL
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (03) : 172 - 180